Estradiol acetate oral - Allergan

Drug Profile

Estradiol acetate oral - Allergan

Alternative Names: Femtrace

Latest Information Update: 15 Jul 2015

Price : $50

At a glance

  • Originator Warner Chilcott
  • Class Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Menopausal syndrome

Most Recent Events

  • 01 Oct 2013 Warner Chilcott has been acquired and merged into Actavis Inc
  • 31 Mar 2005 Launched for Menopausal syndrome in USA (PO) - First global launch
  • 23 Aug 2004 Registered for Menopausal syndrome in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top